tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALXO Stock Latest News

ALX Oncology price target raised to $4 from $3 at Piper Sandler
The FlyALX Oncology price target raised to $4 from $3 at Piper Sandler
1d ago
ALXO
ALX Oncology announces major underwritten public equity offering
PremiumCompany Announcements
ALX Oncology announces major underwritten public equity offering
7d ago
8K
ALXO
ALX Oncology Highlights Biomarker Data and Cash Position
PremiumCompany Announcements
ALX Oncology Highlights Biomarker Data and Cash Position
7d ago
8K
ALXO
ALX Oncology announces new data from Phase 1b/2 trial of evorpacept, Ziihera
PremiumThe Fly
ALX Oncology announces new data from Phase 1b/2 trial of evorpacept, Ziihera
7d ago
ALXO
JAZZ
ALX Oncology Expands Inducement Equity Plan for Hiring
PremiumCompany Announcements
ALX Oncology Expands Inducement Equity Plan for Hiring
16d ago
8K
ALXO
ALX Oncology first patient dosed in Phase 2 ASPEN-09-Breast trial
PremiumThe FlyALX Oncology first patient dosed in Phase 2 ASPEN-09-Breast trial
29d ago
ALXO
ALX Oncology announces data from Phase 2 trial of evorpacept
Premium
The Fly
ALX Oncology announces data from Phase 2 trial of evorpacept
2M ago
ALXO
ALX Oncology initiated with a Buy at Jefferies
Premium
The Fly
ALX Oncology initiated with a Buy at Jefferies
3M ago
ALXO
ALX Oncology Holdings: Buy Rating Backed by Promising Clinical Data and Strategic Initiatives
PremiumRatings
ALX Oncology Holdings: Buy Rating Backed by Promising Clinical Data and Strategic Initiatives
3M ago
ALXO
Alx Oncology Earnings Call: Optimism Amid Challenges
PremiumCompany Announcements
Alx Oncology Earnings Call: Optimism Amid Challenges
3M ago
ALXO
ALX Oncology Reports Promising Q3 2025 Results
PremiumCompany Announcements
ALX Oncology Reports Promising Q3 2025 Results
3M ago
ALXO
ALX Oncology reports Q3 EPS (41c), consensus (37c)
PremiumThe Fly
ALX Oncology reports Q3 EPS (41c), consensus (37c)
3M ago
ALXO
ALX Oncology sees cash runway into 1Q27
PremiumThe FlyALX Oncology sees cash runway into 1Q27
3M ago
ALXO
ALXO Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ALXO Earnings this Week: How Will it Perform?
3M ago
ALXO
Alx Oncology’s ALX2004: A Promising Phase 1 Study Targeting EGFR in Solid Tumors
Premium
Company Announcements
Alx Oncology’s ALX2004: A Promising Phase 1 Study Targeting EGFR in Solid Tumors
3M ago
ALXO
ALX Oncology’s ASPEN-09 Study: A Promising Update for Cancer Treatment
PremiumCompany Announcements
ALX Oncology’s ASPEN-09 Study: A Promising Update for Cancer Treatment
3M ago
ALXO
ALX presents preclinical data, Phase 1 trial-in-progress for ALX2004
PremiumThe Fly
ALX presents preclinical data, Phase 1 trial-in-progress for ALX2004
4M ago
ALXO
ALX Oncology Announces Management Changes Amidst Nasdaq Compliance
PremiumCompany Announcements
ALX Oncology Announces Management Changes Amidst Nasdaq Compliance
5M ago
8K
ALXO
ALX Oncology appoints Klencke as interim CMO
PremiumThe Fly
ALX Oncology appoints Klencke as interim CMO
5M ago
ALXO
Alx Oncology’s Earnings Call: Optimism Amidst Challenges
PremiumCompany AnnouncementsAlx Oncology’s Earnings Call: Optimism Amidst Challenges
5M ago
ALXO
ALX Oncology doses first patient in Phase 1 trial for ALX2004
Premium
The Fly
ALX Oncology doses first patient in Phase 1 trial for ALX2004
6M ago
ALXO
Alx Oncology Faces Nasdaq Delisting Risk Amid Stock Price Slump
Premium
Company Announcements
Alx Oncology Faces Nasdaq Delisting Risk Amid Stock Price Slump
6M ago
ALXO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >